<DOC>
	<DOCNO>NCT02723500</DOCNO>
	<brief_summary>Subjects age 18-85 lung disease undergo hyperpolarized Xenon 129 ( 129-Xe ) MRI Pulmonary Function test development tool evaluate Apparent Diffusion Coefficient ( ADC ) ventilation defect volume obtain analysis hyperpolarized 129-Xe MRI .</brief_summary>
	<brief_title>129 Xenon MRI Chronic Lung Disease</brief_title>
	<detailed_description>Briefly , one two hour visit , subject provide write informed consent undergo : 1. brief medical history vital sign , 2. full pulmonary function test , 3. proton MRI , 4. spin-density and/or diffusion weight 129Xe MRI . Full pulmonary function test include spirometry , plethysmography diffuse capacity carbon monoxide ( DLCO ) , Lung Clearance Index ( LCI ) Airwave Oscillometry ( AO ) perform accord American Thoracic Society ( ATS ) guideline . MedGraphics Elite Series , MedGraphics Corporation . St. Paul , Minnesota USA and/or nDD EasyOne Spirometer , nDD Medical Technologies Inc. Andover , Massachusetts USA use . All measurement perform Pulmonary Function Laboratory Robarts Research Institute . Subjects place 3T Magnetic Resonance ( MR ) scanner 129Xe chest coil fit torso chest . Hearing protection provide subject muffle noise produce gradient radiofrequency ( RF ) coil . A pulse oximeter lead attach subject monitor heart rate oxygen saturation . MRI perform period 30 minute . All subject supplemental oxygen available via nasal cannula flow-rate 2 liter per minute precaution event oxygen desaturation .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<criteria>Subjects male female age 1885 diagnosed lung disease include limited : asthma , emphysema , Chronic Obstructive Pulmonary Disease ( COPD ) , bronchiectasis , sarcoidosis , pulmonary fibrosis , alpha 1antitrypsin deficiency , lymphangioleiomyomatosis ( LAM ) Subject understand study procedure willing participate study indicate signature inform consent Subject must able perform breathhold 16 . Subject judged otherwise stable health basis medical history Subject able perform reproducible pulmonary function test ( i.e. , 3 best acceptable spirogram Forced Expiratory Volume one second ( FEV1 ) value vary 5 % large value 100 ml , whichever great . ) FEV1 &gt; 25 % predict Forced Vital Capacity ( FVC ) &gt; 25 % predict &gt; 0.5 liter Patient , opinion investigator , mentally legally incapacitate , prevent informed consent obtain , read understand write material . Subject daytime room air oxygen saturation ≤ 92 % ± 2 % supine . Patient unable perform spirometry plethysmography maneuver Subject unable tolerate MRI due patient size and/or know history claustrophobia . Patient pregnant lactating In investigator 's opinion , subject suffers physical , psychological condition ( ) might prevent performance MRI , severe claustrophobia . Subject MRI incompatible device metal body remove , include limited pacemaker , neurostimulators , biostimulators , implanted insulin pump , aneurysm clip , bioprosthesis , artificial limb , metallic fragment foreign body , shunt , surgical staple ( include clip metallic suture and/or ear implant . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Pulmonary Function</keyword>
</DOC>